Korean Circ J.  2009 Dec;39(12):519-524. 10.4070/kcj.2009.39.12.519.

Relationship Between Serum Biochemical Markers of Myocardial Fibrosis and Diastolic Function at Rest and With Exercise in Hypertrophic Cardiomyopathy

• Shim CY
• Ha JW
• Choi EY
• Lee HJ
• Moon SH
• Kim JM
• Rim SJ
• Chung N

• KMID: 2225639
• DOI: http://doi.org/10.4070/kcj.2009.39.12.519

Abstract

BACKGROUND AND OBJECTIVES
Recent studies have demonstrated the usefulness of biochemical markers of collagen turnover as markers of myocardial fibrosis in various diseases. In this study, we hypothesized that increased collagen markers in patients with hypertrophic cardiomyopathy (HCM) were correlated with diastolic function at rest and diastolic functional reserve during exercise. SUBJECTS AND METHODS: Thirty-six patients with HCM and 21 controls with normal left ventricular thickness were studied. Mitral septal annular velocities and mitral inflow velocities were measured at rest and during graded supine bicycle exercise (25 W, 3-minute increments) for the assessment of diastolic function at rest and during exercise. By radioimmunoassay, a byproduct of collagen III synthesis (PIIINP) and peptides resulting from collagen I synthesis (PINP) and degradation (ICTP) were measured. The patients with HCM were divided into two groups according to the median value of the PINP/ICTP ratio in the group. RESULTS: At rest, the mitral annular early diastolic velocity (E') was lower and the E/E' was higher in the patients with HCM with high a PINP/ICTP ratio compared with patients with HCM with a low PINP/ICTP ratio and controls (p<0.001, p=0.012). With exercise, the Doppler parameters were increased in all groups, but there was no significant difference in the change in E' and E/E' during exercise according to collagen turnover markers. CONCLUSION: A higher PINP/ICTP ratio was associated with resting diastolic dysfunction in patients with HCM; however, there was no relationship with augmented diastolic dysfunction during exercise. We suggest that the type I collagen synthesis-to-degradation ratio is a useful marker of resting diastolic function in patients with HCM.

Keyword

Cardiomyopathy hypertrophic; Collagen; Myocardial contraction, diastole; Exercise

MeSH Terms

Biomarkers
Cardiomyopathy, Hypertrophic
Collagen
Collagen Type I
Fibrosis
Humans
Peptides
Radioimmunoassay
Collagen
Collagen Type I
Peptides

Reference

1. Maron BJ. Hypertrophic cardiomyopathy. Lancet. 1997. 350:127–133.

2. Jeong JW. Hypertrophic cardiomyopathy. Korean Circ J. 2002. 32:7–14.

3. Tanaka M, Fujiwara H, Onodera T, Wu DJ, Hamashima Y, Kawai C. Quantitative analysis of myocardial fibrosis in normals, hypertensive hearts, and hypertrophic cardiomyopathy. Br Heart J. 1986. 55:575–581.

4. Lopez B, Gonzalez A, Varo N, Laviades C, Querejeta R, Diez J. Biochemical assessment of myocardial fibrosis in hypertensive heart disease. Hypertension. 2001. 38:1222–1226.

5. Diez J, Laviades C, Mayor G, Gil MJ, Monreal I. Increased serum concentrations of procollagen peptides in essential hypertension: relation to cardiac alterations. Circulation. 1995. 91:1450–1456.

6. Lombardi R, Betocchi S, Losi MA, et al. Myocardial collagen turnover in hypertrophic cardiomyopathy. Circulation. 2003. 108:1455–1460.

7. Fassbach M, Schwartzkopff B. Elevated serum markers for collagen synthesis in patients with hypertrophic cardiomyopathy and diastolic dysfunction. Z Kardiol. 2005. 94:328–335.

8. Martos R, Baugh J, Ledwidge M, et al. Diastolic heart failure: evidence of increased myocardial collagen turnover linked to diastolic dysfunction. Circulation. 2007. 115:888–895.

9. Diez J, Laviades C, Monreal I, Gil MJ, Panizo A, Pardo J. Toward the biochemical assessment of myocardial fibrosis in hypertensive patients. Am J Cardiol. 1995. 76:14D–17D.

10. Ihm SH, Youn HJ, Kim SR, et al. Relation between serum carboxy-terminal propeptide of type 1 procollagen (PIP), a marker of myocardial fibrosis, and left ventricular diastolic function in patients with early type 2 diabetes mellitus. Korean Circ J. 2005. 5:500–506.

11. Briguori C, Betocchi S, Romano M, et al. Exercise capacity in hypertrophic cardiomyopathy depends on left ventricular diastolic function. Am J Cardiol. 1999. 84:309–315.

12. Lele SS, Thomson HL, Seo H, Belenkie I, McKenna WJ, Frenneaux MP. Exercise capacity in hypertrophic cardiomyopathy: role of stroke volume limitation, heart rate, and diastolic filling characteristics. Circulation. 1995. 92:2886–2894.

13. Ha JW, Ahn JA, Kim JM, et al. Abnormal longitudinal myocardial functional reserve assessed by exercise tissue Doppler echocardiography in patients with hypertrophic cardiomyopathy. J Am Soc Echocardiogr. 2006. 19:1314–1319.

14. Choi EY, Ha JW, Rim SJ, et al. Incremental value of left ventricular diastolic function reserve index for predicting exercise capacity in patients with hypertrophic cardiomyopathy. J Am Soc Echocardiogr. 2008. 21:487–492.

15. Quinones MA, Waggoner AD, Reduto LA, et al. A new, simplified and accurate method for determining ejection fraction with two-dimentional echocardiography. Circulation. 1981. 64:744–753.

16. Oh JK, Seward JB, Tajik AJ. The Echo Manual. 1999. 2nd ed. Philadelphia: Lippincott Williams & Wilkins.

17. Ha JW, Lee CH, Park S, et al. Gender-related difference in left ventricular diastolic elastance during exercise in patients with diabetes mellitus. Circ J. 2008. 72:1443–1448.

18. Maron BJ, Bonow RO, Cannon RO 3rd, Leon MB, Epstein SE. Hypertrophic cardiomyopathy: interrelations of clinical manifestations, pathophysiology, and therapy. N Engl J Med. 1987. 316:780–789.

19. Burlew BS, Weber KT. Cardiac fibrosis as a cause of diastolic dysfunction. Herz. 2002. 27:92–98.

20. Shirani J, Pick R, Roberts WC, Maron BJ. Morphology and significance of the left ventricular collagen network in young patients with hypertrophic cardiomyopathy and sudden cardiac death. J Am Coll Cardiol. 2000. 35:36–44.